Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MSLI

(MSLI) (MSLI) Stock Price, News & Analysis

(MSLI) logo

About (MSLI) Stock (NASDAQ:MSLI)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$1.30
$1.30
50-Day Range
N/A
52-Week Range
$0.70
$1.33
Volume
N/A
Average Volume
56,140 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.

Remove Ads
Receive MSLI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (MSLI) and its competitors with MarketBeat's FREE daily newsletter.

MSLI Stock News Headlines

Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
See More Headlines

MSLI Stock Analysis - Frequently Asked Questions

(MSLI) (NASDAQ:MSLI) issued its earnings results on Monday, August, 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by $0.03. The business earned $7.73 million during the quarter, compared to the consensus estimate of $17.19 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that (MSLI) investors own include ProMetic Life Sciences (PLI), Palatin Technologies (PTN), Anavex Life Sciences (AVXL), Biocept (BIOC), Can-Fite BioPharma (CANF), InterCloud Systems (ICLD) and Merus Labs International (MSL).

Company Calendar

Last Earnings
8/10/2015
Today
4/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:MSLI
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:MSLI) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners